Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Immunotech Biopharm Ltd ( (HK:6978) ) has issued an update.
Immunotech Biopharm Ltd has outlined the terms of reference for its Nomination Committee, which was established to identify and recommend candidates for the company’s board of directors. The committee is responsible for overseeing board performance evaluations and developing nomination guidelines and a board diversity policy. The committee will consist of at least three directors, with a majority being independent non-executive directors, and will meet at least once annually to fulfill its duties.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. The company focuses on developing and providing innovative biopharmaceutical products and services.
Average Trading Volume: 408,300
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.54B
See more insights into 6978 stock on TipRanks’ Stock Analysis page.